Drug-resistant cytomegalovirus in transplant recipients: a French cohort study (Q42852632)

8 November 2017

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study (English)

1 reference

8 November 2017

0 references

7

Lionel Rostaing

1 reference

8 November 2017

14

Yvon Lebranchu

1 reference

8 November 2017

Sébastien Hantz

1

1 reference

8 November 2017

Françoise Garnier-Geoffroy

2

1 reference

8 November 2017

Marie-Christine Mazeron

3

1 reference

8 November 2017

Isabelle Garrigue

4

1 reference

8 November 2017

Pierre Merville

5

1 reference

8 November 2017

Catherine Mengelle

6

1 reference

8 November 2017

Franck Saint Marcoux

8

1 reference

8 November 2017

Marie Essig

9

1 reference

8 November 2017

Jean-Philippe Rerolle

10

1 reference

8 November 2017

Sébastien Cotin

11

1 reference

8 November 2017

Raphaëlle Germi

12

1 reference

8 November 2017

Sylvie Pillet

13

1 reference

8 November 2017

Pascal Turlure

15

1 reference

8 November 2017

Sophie Alain

16

1 reference

8 November 2017

French CMV Resistance Survey Study Group

17

1 reference

8 November 2017

language of work or name

English

0 references

publication date

20 October 2010

1 reference

Journal of Antimicrobial Chemotherapy

8 November 2017

1 reference

8 November 2017

65

1 reference

8 November 2017

12

1 reference

8 November 2017

2628-2640

1 reference

Infection in solid-organ transplant recipients

8 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Cytomegalovirus in transplantation - challenging the status quo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

How we treat cytomegalovirus in hematopoietic cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Comparison of sequential cytomegalovirus isolates in a patient with lymphoma and failing antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Rapid determination of antiviral drug susceptibility of human cytomegalovirus by real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Detection of ganciclovir resistance after valacyclovir-prophylaxis in renal transplant recipients with active cytomegalovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Antiviral susceptibility testing of cytomegalovirus: criteria for detecting resistance to antivirals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Natural polymorphism of cytomegalovirus DNA polymerase lies in two nonconserved regions located between domains delta-C and II and between domains III and I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Incidence and clinical features of ganciclovir-resistant cytomegalovirus disease in heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Ganciclovir-resistant cytomegalovirus in organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Preemptive versus sequential prophylactic-preemptive treatment regimens for cytomegalovirus in renal transplantation: comparison of treatment failure and antiviral resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Resistance pattern of cytomegalovirus (CMV) after oral valganciclovir therapy in transplant recipients at high-risk for CMV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

Valganciclovir in adult solid organ transplant recipients: pharmacokinetic and pharmacodynamic characteristics and clinical interpretation of plasma concentration measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ368

21 January 2018

Identifiers

DOI

10.1093/JAC/DKQ368

1 reference

release_2bfbqdx575f6xp5buv4pdjujuu

8 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2bfbqdx575f6xp5buv4pdjujuu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference